Biocompatibility to Reduce Thrombogenicity of Intracoronary Stents

Publisher： Karger

E-ISSN： 1660-3818|26|2|37-41

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.26, Iss.2, 2004-11, pp. : 37-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does a Carbon Ion-Implanted Surface Reduce the Restenosis Rate of Coronary Stents?

By  

Cardiology, Vol. 104, Iss. 2, 2005-08 ,pp. : 72-75

Karger

Access to resources Recommend Favorite

In vitro Biocompatibility Analyses of Stents Coated with Diamond-Like Carbon by Flow Cytometry, Cell Growth Assays and Electron Microscopy

By  

Transfusion Medicine and Hemotherapy, Vol. 27, Iss. 4, 2000-08 ,pp. : 200-206

Karger

Access to resources Recommend Favorite

A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 2, 2018-02 ,pp. : 234-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

A case of in vivo thrombogenicity of an externalized Riata ST lead

By Ricciardi Danilo   La Meir Mark   de Asmundis Carlo   Brugada Pedro  

EP-Europace, Vol. 15, Iss. 3, 2013-03 ,pp. : 428-428

Oxford University Press

Access to resources Recommend Favorite

New‐generation drug‐eluting stents reduce stent thrombosis and myocardial infarction: A propensity‐score‐adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche Dell'Emilia‐Romagna)

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 5, 2015-04 ,pp. : 797-806

John Wiley & Sons Inc

Access to resources Recommend Favorite